Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 2000 Jan 25;162(2):216–220.

The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach

A M Holbrook 1, R Crowther 1, A Lotter 1, C Cheng 1, D King 1
PMCID: PMC1232275  PMID: 10674058

Abstract

Insomnia, or the dissatisfaction with the quantity, quality or timing of sleep, is a common complaint. Because the definition of "normal" sleep is not well established, the estimates of the prevalence and severity of insomnia vary widely. Insomnia is often secondary to underlying psychiatric and medical conditions, and these should be evaluated and treated as a first measure. Nonpharmacological interventions for insomnia including sleep hygiene manoeuvres and exercise are recommended, although the success of these interventions has not been well documented. Benzodiazepines have been the pharmacologic agents of choice for the treatment of insomnia, but there is reason to exercise caution with their use; their overall benefit compared with placebo appears to be minor, and they are often associated with adverse cognitive effects. Unfortunately, no other class of drugs has proven to be superior to the benzodiazepines in terms of benefit:risk ratio. Given the importance of sleep for health and normal daily functioning the diagnosis, prognosis and treatment of insomnia should be a research priority.

Full Text

The Full Text of this article is available as a PDF (209.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ancoli-Israel S., Kripke D. F. Prevalent sleep problems in the aged. Biofeedback Self Regul. 1991 Dec;16(4):349–359. doi: 10.1007/BF00999989. [DOI] [PubMed] [Google Scholar]
  2. Appels A., de Vos Y., van Diest R., Höppner P., Mulder P., de Groen J. Are sleep complaints predictive of future myocardial infarction? Act Nerv Super (Praha) 1987 Jun;29(2):147–151. [PubMed] [Google Scholar]
  3. Baillargeon L., Demers M., Grégoire J. P., Pépin M. Enquête sur le traitement de l'insomnie par les omnipraticiens. Can Fam Physician. 1996 Mar;42:426–432. [PMC free article] [PubMed] [Google Scholar]
  4. Baillargeon L. Traitements cognitifs et comportementaux de l'insomnie. Une alternative à la pharmacothérapie. Can Fam Physician. 1997 Feb;43:290–296. [PMC free article] [PubMed] [Google Scholar]
  5. Bixler E. O., Kales A., Soldatos C. R., Kales J. D., Healey S. Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry. 1979 Oct;136(10):1257–1262. doi: 10.1176/ajp.136.10.1257. [DOI] [PubMed] [Google Scholar]
  6. Bliwise D. L., King A. C., Harris R. B., Haskell W. L. Prevalence of self-reported poor sleep in a healthy population aged 50-65. Soc Sci Med. 1992 Jan;34(1):49–55. doi: 10.1016/0277-9536(92)90066-y. [DOI] [PubMed] [Google Scholar]
  7. Bootzin R. R., Perlis M. L. Nonpharmacologic treatments of insomnia. J Clin Psychiatry. 1992 Jun;53 (Suppl):37–41. [PubMed] [Google Scholar]
  8. Brzezinski A. Melatonin in humans. N Engl J Med. 1997 Jan 16;336(3):186–195. doi: 10.1056/NEJM199701163360306. [DOI] [PubMed] [Google Scholar]
  9. Busto U., Lanctôt K. L., Isaac P., Adrian M. Benzodiazepine use and abuse in Canada. CMAJ. 1989 Nov 1;141(9):917–921. [PMC free article] [PubMed] [Google Scholar]
  10. Davidson W., Molloy D. W., Somers G., Bédard M. Relation between physician characteristics and prescribing for elderly people in New Brunswick. CMAJ. 1994 Mar 15;150(6):917–921. [PMC free article] [PubMed] [Google Scholar]
  11. Dotto L. Sleep stages, memory and learning. CMAJ. 1996 Apr 15;154(8):1193–1196. [PMC free article] [PubMed] [Google Scholar]
  12. Ettinger W. H., Jr, Burns R., Messier S. P., Applegate W., Rejeski W. J., Morgan T., Shumaker S., Berry M. J., O'Toole M., Monu J. A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis. The Fitness Arthritis and Seniors Trial (FAST). JAMA. 1997 Jan 1;277(1):25–31. [PubMed] [Google Scholar]
  13. Everitt D. E., Avorn J., Baker M. W. Clinical decision-making in the evaluation and treatment of insomnia. Am J Med. 1990 Sep;89(3):357–362. doi: 10.1016/0002-9343(90)90349-i. [DOI] [PubMed] [Google Scholar]
  14. Ford D. E., Kamerow D. B. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA. 1989 Sep 15;262(11):1479–1484. doi: 10.1001/jama.262.11.1479. [DOI] [PubMed] [Google Scholar]
  15. Gillin J. C., Byerley W. F. Drug therapy: The diagnosis and management of insomnia. N Engl J Med. 1990 Jan 25;322(4):239–248. doi: 10.1056/NEJM199001253220406. [DOI] [PubMed] [Google Scholar]
  16. Glass R. M. Benzodiazepine prescription regulation. Autonomy and outcome. JAMA. 1991 Nov 6;266(17):2431–2433. [PubMed] [Google Scholar]
  17. Greenblatt D. J., Harmatz J. S., Engelhardt N., Shader R. I. Pharmacokinetic determinants of dynamic differences among three benzodiazepine hypnotics. Flurazepam, temazepam, and triazolam. Arch Gen Psychiatry. 1989 Apr;46(4):326–332. doi: 10.1001/archpsyc.1989.01810040032006. [DOI] [PubMed] [Google Scholar]
  18. Greenblatt D. J., Shader R. I., Abernethy D. R. Drug therapy. Current status of benzodiazepines. N Engl J Med. 1983 Aug 18;309(7):410–416. doi: 10.1056/NEJM198308183090705. [DOI] [PubMed] [Google Scholar]
  19. Hauri P. J., Esther M. S. Insomnia. Mayo Clin Proc. 1990 Jun;65(6):869–882. doi: 10.1016/s0025-6196(12)62578-6. [DOI] [PubMed] [Google Scholar]
  20. Hauri P. Treating psychophysiologic insomnia with biofeedback. Arch Gen Psychiatry. 1981 Jul;38(7):752–758. doi: 10.1001/archpsyc.1981.01780320032002. [DOI] [PubMed] [Google Scholar]
  21. Hemmelgarn B., Suissa S., Huang A., Boivin J. F., Pinard G. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA. 1997 Jul 2;278(1):27–31. [PubMed] [Google Scholar]
  22. Hindmarch I., Ott H. Sleep, benzodiazepines and performance: issues and comments. Psychopharmacology Suppl. 1984;1:194–202. doi: 10.1007/978-3-642-69659-6_17. [DOI] [PubMed] [Google Scholar]
  23. Holbrook A. M., Crowther R., Lotter A., Cheng C., King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ. 2000 Jan 25;162(2):225–233. [PMC free article] [PubMed] [Google Scholar]
  24. Kales A., Soldatos C. R., Kales J. D. Sleep disorders: insomnia, sleepwalking, night terrors, nightmares, and enuresis. Ann Intern Med. 1987 Apr;106(4):582–592. doi: 10.7326/0003-4819-106-4-582. [DOI] [PubMed] [Google Scholar]
  25. King A. C., Oman R. F., Brassington G. S., Bliwise D. L., Haskell W. L. Moderate-intensity exercise and self-rated quality of sleep in older adults. A randomized controlled trial. JAMA. 1997 Jan 1;277(1):32–37. [PubMed] [Google Scholar]
  26. Kripke D. F., Simons R. N., Garfinkel L., Hammond E. C. Short and long sleep and sleeping pills. Is increased mortality associated? Arch Gen Psychiatry. 1979 Jan;36(1):103–116. doi: 10.1001/archpsyc.1979.01780010109014. [DOI] [PubMed] [Google Scholar]
  27. Kruse W. H. Problems and pitfalls in the use of benzodiazepines in the elderly. Drug Saf. 1990 Sep-Oct;5(5):328–344. doi: 10.2165/00002018-199005050-00003. [DOI] [PubMed] [Google Scholar]
  28. Kupfer D. J., Reynolds C. F., 3rd Management of insomnia. N Engl J Med. 1997 Jan 30;336(5):341–346. doi: 10.1056/NEJM199701303360506. [DOI] [PubMed] [Google Scholar]
  29. Lasagna L. Over-the-counter hypnotics and chronic insomnia in the elderly. J Clin Psychopharmacol. 1995 Dec;15(6):383–386. doi: 10.1097/00004714-199512000-00001. [DOI] [PubMed] [Google Scholar]
  30. Lexchin J. Debating benzodiazepine use. Can Fam Physician. 1995 Aug;41:1293–1295. [PMC free article] [PubMed] [Google Scholar]
  31. Maczaj M. Pharmacological treatment of insomnia. Drugs. 1993 Jan;45(1):44–55. doi: 10.2165/00003495-199345010-00005. [DOI] [PubMed] [Google Scholar]
  32. McGinnis J. M., Foege W. H. Actual causes of death in the United States. JAMA. 1993 Nov 10;270(18):2207–2212. [PubMed] [Google Scholar]
  33. McIsaac W., Naylor C. D., Anderson G. M., O'Brien B. J. Reflections on a month in the life of the Ontario Drug Benefit Plan. CMAJ. 1994 Feb 15;150(4):473–477. [PMC free article] [PubMed] [Google Scholar]
  34. Mellinger G. D., Balter M. B., Uhlenhuth E. H. Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiatry. 1985 Mar;42(3):225–232. doi: 10.1001/archpsyc.1985.01790260019002. [DOI] [PubMed] [Google Scholar]
  35. Millar W. A trend to a healthier lifestyle. Health Rep. 1991;3(4):363–370. [PubMed] [Google Scholar]
  36. Morgan K., Healey D. W., Healey P. J. Factors influencing persistent subjective insomnia in old age: a follow-up study of good and poor sleepers aged 65 to 74. Age Ageing. 1989 Mar;18(2):117–122. doi: 10.1093/ageing/18.2.117. [DOI] [PubMed] [Google Scholar]
  37. Morin C. M., Colecchi C., Stone J., Sood R., Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA. 1999 Mar 17;281(11):991–999. doi: 10.1001/jama.281.11.991. [DOI] [PubMed] [Google Scholar]
  38. Morin C. M., Culbert J. P., Schwartz S. M. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry. 1994 Aug;151(8):1172–1180. doi: 10.1176/ajp.151.8.1172. [DOI] [PubMed] [Google Scholar]
  39. Murtagh D. R., Greenwood K. M. Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol. 1995 Feb;63(1):79–89. doi: 10.1037//0022-006x.63.1.79. [DOI] [PubMed] [Google Scholar]
  40. Neutel C. I. Risk of traffic accident injury after a prescription for a benzodiazepine. Ann Epidemiol. 1995 May;5(3):239–244. doi: 10.1016/1047-2797(94)00112-7. [DOI] [PubMed] [Google Scholar]
  41. O'Donovan M. C., McGuffin P. Short acting benzodiazepines. BMJ. 1993 Apr 10;306(6883):945–946. doi: 10.1136/bmj.306.6883.945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Ohayon M. M., Caulet M. Psychotropic medication and insomnia complaints in two epidemiological studies. Can J Psychiatry. 1996 Sep;41(7):457–464. doi: 10.1177/070674379604100711. [DOI] [PubMed] [Google Scholar]
  43. Pollak C. P., Perlick D., Linsner J. P., Wenston J., Hsieh F. Sleep problems in the community elderly as predictors of death and nursing home placement. J Community Health. 1990 Apr;15(2):123–135. doi: 10.1007/BF01321316. [DOI] [PubMed] [Google Scholar]
  44. Radecki S. E., Brunton S. A. Management of insomnia in office-based practice. National prevalence and therapeutic patterns. Arch Fam Med. 1993 Nov;2(11):1129–1134. doi: 10.1001/archfami.2.11.1129. [DOI] [PubMed] [Google Scholar]
  45. Ray W. A., Fought R. L., Decker M. D. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol. 1992 Oct 1;136(7):873–883. doi: 10.1093/aje/136.7.873. [DOI] [PubMed] [Google Scholar]
  46. Ray W. A., Griffin M. R., Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA. 1989 Dec 15;262(23):3303–3307. [PubMed] [Google Scholar]
  47. Ray W. A., Griffin M. R., Schaffner W., Baugh D. K., Melton L. J., 3rd Psychotropic drug use and the risk of hip fracture. N Engl J Med. 1987 Feb 12;316(7):363–369. doi: 10.1056/NEJM198702123160702. [DOI] [PubMed] [Google Scholar]
  48. Reinken J., Sparrow M., Campbell A. J. The giving and taking of psychotropic drugs in New Zealand. N Z Med J. 1982 Jul 28;95(712):489–492. [PubMed] [Google Scholar]
  49. Reynolds C. F., 3rd, Kupfer D. J., Buysse D. J., Coble P. A., Yeager A. Subtyping DSM-III-R primary insomnia: a literature review by the DSM-IV Work Group on Sleep Disorders. Am J Psychiatry. 1991 Apr;148(4):432–438. doi: 10.1176/ajp.148.4.432. [DOI] [PubMed] [Google Scholar]
  50. Ried L. D., Johnson R. E., Gettman D. A. Benzodiazepine exposure and functional status in older people. J Am Geriatr Soc. 1998 Jan;46(1):71–76. doi: 10.1111/j.1532-5415.1998.tb01016.x. [DOI] [PubMed] [Google Scholar]
  51. Rosser W. W. Anxiety over benzodiazepines. Can Fam Physician. 1995 May;41:760, 763-5, 772-6. [PMC free article] [PubMed] [Google Scholar]
  52. Serfaty M., Masterton G. Fatal poisonings attributed to benzodiazepines in Britain during the 1980s. Br J Psychiatry. 1993 Sep;163:386–393. doi: 10.1192/bjp.163.3.386. [DOI] [PubMed] [Google Scholar]
  53. Shader R. I., Greenblatt D. J., Balter M. B. Appropriate use and regulatory control of benzodiazepines. J Clin Pharmacol. 1991 Sep;31(9):781–784. doi: 10.1002/j.1552-4604.1991.tb01910.x. [DOI] [PubMed] [Google Scholar]
  54. Spielman A. J., Saskin P., Thorpy M. J. Treatment of chronic insomnia by restriction of time in bed. Sleep. 1987 Feb;10(1):45–56. [PubMed] [Google Scholar]
  55. Steinberg A. D. Should chloral hydrate be banned? Pediatrics. 1993 Sep;92(3):442–446. [PubMed] [Google Scholar]
  56. Tamblyn R. M., McLeod P. J., Abrahamowicz M., Monette J., Gayton D. C., Berkson L., Dauphinee W. D., Grad R. M., Huang A. R., Isaac L. M. Questionable prescribing for elderly patients in Quebec. CMAJ. 1994 Jun 1;150(11):1801–1809. [PMC free article] [PubMed] [Google Scholar]
  57. Thomas R. E. Benzodiazepine use and motor vehicle accidents. Systematic review of reported association. Can Fam Physician. 1998 Apr;44:799–808. [PMC free article] [PubMed] [Google Scholar]
  58. Thompson T. L., 2nd, Moran M. G., Nies A. S. Drug therapy: Psychotropic drug use in the elderly (first of two parts). N Engl J Med. 1983 Jan 20;308(3):134–138. doi: 10.1056/NEJM198301203080305. [DOI] [PubMed] [Google Scholar]
  59. Tinetti M. E., Speechley M., Ginter S. F. Risk factors for falls among elderly persons living in the community. N Engl J Med. 1988 Dec 29;319(26):1701–1707. doi: 10.1056/NEJM198812293192604. [DOI] [PubMed] [Google Scholar]
  60. Triazolam in the elderly. N Engl J Med. 1991 Dec 12;325(24):1742–1745. doi: 10.1056/NEJM199112123252412. [DOI] [PubMed] [Google Scholar]
  61. Webb W. B. Sleep in industrialized settings in the northern hemisphere. Psychol Rep. 1985 Oct;57(2):591–598. doi: 10.2466/pr0.1985.57.2.591. [DOI] [PubMed] [Google Scholar]
  62. Wingard D. L., Berkman L. F. Mortality risk associated with sleeping patterns among adults. Sleep. 1983;6(2):102–107. doi: 10.1093/sleep/6.2.102. [DOI] [PubMed] [Google Scholar]
  63. Wysowski D. K., Barash D. Adverse behavioral reactions attributed to triazolam in the Food and Drug Administration's Spontaneous Reporting System. Arch Intern Med. 1991 Oct;151(10):2003–2008. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES